ICH Project ICH Japan Symposium 2010

December 22, 2010

ICH Japan Symposium 2010 (23rd ICH Imminent Report Meeting)
ICH Public Meeting: ICH Japan Symposium 2010


As a forum for presentation and discussion of the outcomes of the ICH Fukuoka Meeting (November 6-11, 2010, Fukuoka, Japan), the third ICH regional meeting in the Japan region was held on December 2, 2010, at Tsuda Hall, Tokyo, under the title "ICH Japan Symposium 2010".

The symposium was held with the following program. In Part I, presentations and discussions on the progress and achievements of the Expert Working Groups at the Fukuoka Conference were made as trends in each topic. In Part II, a special session, a general discussion on pharmacovigilance was held with the participation of experts from both the business and government sides. This session included a comprehensive discussion on E2-related guidelines (E2A, E2B, E2D, E2E, and E2F), including the Periodic Safety Update Report (PSUR) for E2C marketed drugs, and gaps among regions and guidelines.

The program, presentation timetable, and presentation materials of this symposium are attached below as files for direct viewing.

In addition, the workshop materials on "Trends in Quality Topics: Q-IWG Quality Implementation Working Group" in the collection of presentation materials can be viewed at the ICH Q8, Q9, and Q10 Guidelines Operational Practices Workshop.

Unauthorized copying or reproduction of the attached materials is prohibited.

Date, time and place

Date and time Location
Thursday, December 2, 2010 10:00-16:40 Tsuda Hall
1-18-24 Sendagaya, Shibuya-ku, Tokyo

Information, Program

Presentation Materials

Please scroll horizontally.

Presentation Speakers
00_Opening Remarks (42KB) Kohei Wada (Daiichi Sankyo)
Part I: Topic Trends 01_Past ICH (533KB) Riko Suzuki (Ministry of Health, Labour and Welfare)
02_ICH Latest Trends (255KB) KURAJIRO KISHI (JPMA)
Trends in the topic of electronic standards for the communication of pharmaceutical regulatory information 03_M2:Electronic standards for the communication of regulatory information (250KB) Takeshi Adachi (Janssen Pharma)
04_E2B(R3): Data items and message specifications for transmitting individual case safety reports (364KB) Ayumi Endo (Japan Health Sciences Agency)
05_M5: Data items and criteria for drug dictionary (472KB) Izumi Ohba (NIH)
06_M8 (eCTD): Electronic application form (283KB) Koji Shomoto (Nippon Boehringer Ingelheim)
Trends in Efficacy Topics 07_E2C(R2): Periodic post-marketing safety report (178KB) Tomoko Okudaira (Japan Research Institute for Human Health and Welfare)
08_E14 IWG: Clinical evaluation of QT prolongation and severe arrhythmia (154KB) Maki Ito (Shionogi)
Trends in Safety Topics 09_S6(R1): Non-clinical safety evaluation of biopharmaceuticals (review) (297KB) Kazuto WATABE (Chugai Pharmaceutical)
10_S10:Photo safety study (333KB) Dai Nakae (Tokyo Metropolitan Institute of Public Health)
11_M3(R2) IWG: Timing of Non-clinical Studies (169KB) Fumiro Sagami (Eisai)
12_M6, GTDG: Virus/vector shedding and transmission, Gene therapeutic drug discovery group (606KB) Koh Toriumi (POC Clinical Research)
13_M7: Evaluation and management of DNA reactive impurities (869KB) Masamitsu HONMA (National Institute of Health Sciences)
Trends in Quality Topics 14_Q3D:Metallic impurities (109KB) Masayuki MISHIMA (Chugai Pharmaceutical)
15_Q4B: Evaluation and recommendation for mutual use of pharmacopoeia text in ICH region (244KB) Masaaki Wada (Shionogi)
16_Q11: Development and manufacturing of active pharmaceutical ingredients for chemical products and biopharmaceuticals (165KB) Kazunori Takagi (NIHS)
17_Q-IWG: Quality Implementation Working Group (139KB) Yoshihiro Matsuda (JAEA)
Part II: Special Session Pharmacovigilance 18_PV Panel 1: Summary (376KB) Daisaku Sato (MHLW)
19_PV Panel 2 Industry side (173KB) Yoko Hattori (Daiichi Sankyo)
20_PV Panel 3: Administrative side (133KB) Tomoko Okudaira (NIH)
 

Share this page

TOP